Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Landos Biopharma Inc (LABP)

  • Technical Exchange News
  • May 24, 2024, 07:08 UTC
  • 30
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Landos Biopharma, Inc. - Common Stock.

Comment Full text

Landos Biopharma Inc (LABP)

  • Technical Exchange News
  • May 24, 2024, 07:08 UTC
  • 30
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Landos Biopharma, Inc. - Common Stock. New value: Landos Biopharma, Inc. - Common Stock.

Comment Full text

Landos Biopharma Inc (LABP)

  • Technical Exchange News
  • May 24, 2024, 07:08 UTC
  • 27
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Landos Biopharma, Inc. - Common Stock.

Comment Full text

Vivos Therapeutics (VVOS)

  • Technical Exchange News
  • May 24, 2024, 02:03 UTC
  • 29
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Procaps Group SA (PROC)

  • Technical Exchange News
  • May 24, 2024, 02:02 UTC
  • 30
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

Nexalin Technology Inc (NXLIW)

  • Technical Exchange News
  • May 24, 2024, 02:02 UTC
  • 28
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Nexalin Technology Inc (NXL)

  • Technical Exchange News
  • May 24, 2024, 02:02 UTC
  • 28
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

eFFECTOR Therapeutics Inc. (EFTR)

  • Technical Exchange News
  • May 24, 2024, 02:02 UTC
  • 32
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

eFFECTOR Therapeutics Inc. (EFTRW)

  • Technical Exchange News
  • May 24, 2024, 02:02 UTC
  • 28
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Enveric Biosciences Inc. (ENVB)

  • Technical Exchange News
  • May 24, 2024, 02:02 UTC
  • 28
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 584
  • 585
  • 586
  • 587
  • 588
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2382)
  • SEC News(191987)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125306)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin